PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases

L. M. Gomez, J. M. Anaya, C. I. Gonzalez, R. Pineda-Tamayo, W. Otero, A. Arango, J. Martín

Research output: Contribution to journalResearch Articlepeer-review

115 Scopus citations


A functional single nucleotide polymorphism (SNP) C1858T in the protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene encoding an intracellular phosphatase with negative regulatory effects on T-cell activation is associated with some autoimmune diseases in Caucasians. Taking into account firstly, that SNP frequencies may vary across populations and, secondly, that replication studies are important to confirm previous associations, we examined the influence of PTPN22 polymorphism in 621 Colombian patients with four autoimmune diseases. Accordingly, 298 patients with rheumatoid arthritis (RA), 143 with systemic lupus erythematosus (SLE), 70 with primary Sjogren's syndrome (pSS) and 110 with Type 1 diabetes (T1D) were studied. The control group consisted of 308 matched healthy individuals. Genotyping of PTPN22 was performed by the real-time polymerase chain reaction technology, using the TaqMan 5′-allele discrimination assay. The 1858 T allele was found to be a risk factor for pSS (odds ratio (OR)=2.42), SLE (OR=2.56), and T1D (OR =1.83). A lower but nonsignificant trend was observed for RA (OR=1.26). These results confirm the influence of PTPN22 in autoimmunity and indicate that autoimmune phenotypes could represent pleiotropic outcomes of nonspecific disease genes that underlie similar immunogenetic mechanisms.

Original languageEnglish (US)
Pages (from-to)628-631
Number of pages4
JournalGenes and Immunity
Issue number7
StatePublished - Oct 2005

All Science Journal Classification (ASJC) codes

  • Immunology
  • Genetics
  • Genetics(clinical)


Dive into the research topics of 'PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases'. Together they form a unique fingerprint.

Cite this